OI Ljubljana
Sl

Ongoing research grants

CodeProgramme titlePeriodPrincipal Investigator at the Insitute of OncologyFunding Agency
J3-3083 Vascularization and vascular effects as predictive factors for local ablative techniques 1.9.2021 - 31.8.2024acad. prof. dr. Serša GregorSRA
J3-3084 Inducible programming of CAR T cell intrinsic properties for cancer immunotherapy 1.9.2021 - 31.8.2024dr. Anže Smole (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)SRA
J3-2528 Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors 1.9.2020 - 31.8.2023prof. dr. Maja ČemažarCompleted research projects
J3-2529 Role of endothelium in tumor response to radiotherapy 1.9.2020 - 31.8.2023dr. Boštjan MarkelcCompleted research projects
J4-2546 Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours 1.9.2020 - 31.8.2023prof. dr. Nataša Tozon (Veterinary Faculty)/prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)Completed research projects
J4-2594 The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity 1.9.2020 - 31.8.2023prof. dr. Mateja Erdani Kreft (Faculty of Medicine)/ prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)Completed research projects
Z3-2651 Electrochemotherapy as in situ vaccination therapy 1. 9. 2020 - 31. 8. 2023dr. Katja Uršič ValentinuzziCompleted research projects
Z3-1873 A novel vascular targeted approach based on gene therapy silencing two independent signaling pathways in combination with radiotherapy 1.7.2019 - 30.6.2022dr. Monika SavarinSRA
P3-0003 Development and evaluation of new approaches to cancer treatment 1. 7. 2004 – 31. 12. 2027Acad. Prof. Serša GregorSRA
NIH- DNA-specific pattern recognition receptor activation following DNA electroporation 1.7.2015 - 31.12.2022prof. dr. Maja ČemažarCompleted international projects
BI-US-22-24-026 Factors affecting combined electrochemotherapy with immunogene therapy of cancer 1. 7. 2022-30. 6. 2024Acad. Prof. Serša GregorBilateral cooperation
BI-US-22-24-070 Bridging the gap between three-dimensional biomimetic vascular models and in vivo tumor vasculature 1. 7. 2022-30. 6. 2024dr. Boštjan MarkelcBilateral cooperation
PROTEUS- In vivo gene therapy targeting of skin-resident immune cells 1.1.2019 - 30.9.2021dr. Urška KamenšekCompleted international projects
- Smartgene.Si 1.7.2018 - 30.9.2021acad. prof. dr. Gregor SeršaCompleted international projects
Z3-1871 Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer 1.7.2019 - 30.6.2021dr. Maša BošnjakCompleted research projects
J2-9225 Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields 1.7.2018 - 30.6.2021prof. dr. Damijan Miklavčič (Faculty of Electrical Engineering/ acad. prof. dr. Gregor Serša Institute of Oncology LjubljanaCompleted research projects
J3-9269 Clinical pharmacological approach to optimization of therapeutic concentration of bleomycin treatment with electrochemotherapy 1.7.2018 - 30.6.2021acad. prof. dr. Serša GregorCompleted research projects
J1-8140 Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard 1.5.2017 - 30.4.2021prof. dr. Filipič Metka (National Institute of Biology) / prof. dr. Maja Čemažar (Institute of Oncology Ljubljana)Completed research projects
N3-0059 Plasma-assisted wound treatment and topical introduction of molecules 1.1.2017 - 31.12.2020dr. Uroš Cvelbar (Jozef Stefan Institute)/acad. prof. dr. Serša Gregor (Institute of Oncology Ljubljana)Completed research projects
BI-US-18-20-027 Radiotherapy induced expression of DNA sensors and cytokines in tumor cells 1.10.2018 - 30.9.2020prof. dr. Maja ČemažarCompleted international projects
J3-8202 Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and interleukin-12 gene therapy boost 1.5.2017 - 30.4.2021prof. dr. Maja ČemažarCompleted research projects
J4-8227 Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy 1.5.2017 - 30.4.2020prof. dr. Kos Janko (Univerza v Ljubljani, Fakulteta za farmacijo/IJS)/ acad. prof. dr. Gregor Serša (Onkološki inštitut)Completed research projects
Z3-8204 Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect 1.4.2018 - 31.3.2020dr. Tanja JesenkoCompleted research projects
BI-AT-18-19-003 Cancer stem cell (CSC)-associated exosomes as regulators of tumor radiation response 1.1.2018 - 31.12.2019prof. dr. Maja ČemažarCompleted research projects
L2-7550 Electrospun nanofibrous materials for solid state drug delivery system 1.3.2016 - 28.2.2019prof. dr. Igor Emri /acad. prof. dr. Gregor Serša (Institute of Oncology Ljubljana)Completed research projects
J3-7460 Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model 1.1.2016 - 31.12.2018prof. dr. Strojan Primož/Institute of Oncology LjubljanaCompleted research projects
LEA-EBAM- European Laboratory of Pulsed Electric Fields Applications in Biology and Medicine acad. prof. dr. Gregor SeršaCompleted international projects

 

SRA – Slovenian Research Agency (https://www.arrs.gov.si)

NIH – National Institute of Health (https://www.nih.gov/)

LEA EBAM - The European Associated Laboratory (LEA) entitled “Pulsed Electric Fields Applications in Biology and Medicine (http://lea-ebam.cnrs.fr/)

 

 

© 2019 - Institute of Oncology Ljubljana
Accessibility(CTRL+F2)
color contrast
text size
highlighting content
zoom in